About Concateno
Concateno is a Healthcare company based in Wynnum (Australia) founded in 2015, and was acquired by Abbott in June 2009. Drug research and development services are provided to biopharma firms. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services.
Company details
Concateno was established in 2015 and is based in Wynnum, Australia. Drug research and development services are delivered to the biopharma sector, supporting various stages of pharmaceutical innovation. Operations encompass preclinical testing, formulation development, and analytical services. The company maintains a focus on regulatory compliance and quality standards within the Australian life sciences landscape, serving international clients through its specialized expertise.
- Headquarters Wynnum, Australia
- Stage Acquired
- SectorsHealthcare
- Website concateno.com
- Acquired by Abbott (Jun 2009)
- Investors
- Acquired byAbbott
(Jun 2009)
Investors in Concateno
Concateno has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Rapid diagnostics products and solutions for point-of-care testing are provided. | 1900 | globalpointofcare.abbott | Waukegan, United States |
Investor details for Concateno
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Concateno
2 dated milestones of Concateno across 6 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Abbott.
- Founded Concateno is founded.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Concateno
Concateno was founded in 2015.
Concateno is headquartered in Wynnum, Australia. It is registered at Wynnum, Queensland, Australia.
Concateno was established in 2015 and is based in Wynnum, Australia. Drug research and development services are delivered to the biopharma sector, supporting various stages of pharmaceutical innovation. Operations encompass preclinical testing, formulation development, and analytical services. The company maintains a focus on regulatory compliance and quality standards within the Australian life sciences landscape, serving international clients through its specialized expertise.
Concateno has 1 investor. Key investors include Abbott Global Point of Care.
Yes. Concateno was acquired by Abbott in June 2009.